XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 14, 2023
Oct. 25, 2021
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Apr. 30, 2024
Apr. 21, 2023
Dec. 31, 2022
Oct. 03, 2022
Dec. 31, 2021
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                          
Payments to acquire restricted investments   $ 204,000,000                      
Cash                 $ 187,475,000        
Assets held-in-trust, noncurrent     $ 23,626,000   $ 23,626,000   $ 22,890,000            
Term of restricted investments         185 days                
Cash and cash equivalents     592,000   $ 592,000   14,000            
Cash, FDIC insured amount     250,000   250,000                
Warrant liability issuance costs   491,000                      
Payment of fess to financial advisor   175,000                      
Deferred underwriting compensation     3,675,000   3,675,000           $ 7,000,000    
Waived their right to their deferred underwriting compensation     3,417,000   3,417,000                
Warrant liability     $ 258,000 $ 258,000              
Deferred underwriting compensation forfeited, percentage     47.50%   47.50%           47.50%    
Minimum net worth required for compliance     $ 5,000,001   $ 5,000,001                
Unrecognized tax benefits     0   0   0            
Interest and penalties, unrecognized tax benefits     $ 0   $ 0   $ 0            
IPO [Member]                          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                          
Total costs incurred in connection with preparation for the initial public offering   11,725,000                      
Offering costs   725,000                      
Underwriters discount   $ 11,000,000                      
Deferred compensation liability, percentage   3.50% 52.50%   52.50%     52.50%          
Class A Ordinary Shares Subject To Possible Redemption [Member]                          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                          
Costs allocated to equity instruments   $ 11,234,000                      
Common Class A [Member]                          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                          
Number of shareholders elected to redeem 167                        
Stock redeemed or called during period, Shares 17,910,004         17,910,004 17,910,004            
Percentage of common stock 89.60%                        
Deferred underwriting compensation             $ 3,675,000       $ 7,000,000    
Public Offering (in shares)     2,089,996   2,089,996   2,089,996     20,000,000   20,000,000 20,000,000
Common Class A [Member] | IPO [Member]                          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                          
Stock issued during period, Shares   20,000,000                      
Warrant [Member] | Common Class A [Member]                          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                          
Antidilutive securities excluded from computation of earnings per share         20,500,000